You are here

Ophthotech

3 Biotechs That Play Well with Others

Motley Fool

Thu, 10/1/15 - 09:39 am

The Next Blockbusters Could Be Balms For Aging Eyes

Investors.com

Thu, 09/3/15 - 09:10 am

age-related macular degeneration

Applied Genetic Technologies

Avalanche Biotechnologies

5 Drugs That Investors May Be Undervaluing

Motley Fool

Mon, 07/13/15 - 11:04 am

Amicus Therapeutics

Gilead Sciences

3 Little-Known Biotechs Working On Potential Blockbusters

Motley Fool

Sun, 03/29/15 - 11:42 am

Esperion Therapeutics. ETC-1002

2 Tiny Biotechs That Could Have Blockbuster Opportunity

Motley Fool

Sat, 03/7/15 - 11:23 am

Portola Pharmaceuticals

This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market

Motley Fool

Mon, 02/2/15 - 10:08 am

wet age-related macular degeneration

Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel

The Fly on the Wall

Tue, 05/20/14 - 11:24 am

wet age-related macular degeneration

How The Global Pharma Industry Will Shape Up In The Next 5 Years?

Seeking Alpha

Wed, 12/4/13 - 11:38 am

Bristol-Myers Squibb

Fresh burst of biotech IPO pitches launches a busy Q4 season

Fierce Biotech

Tue, 10/22/13 - 11:51 am

Foundation Medicine

Ophthotech, Foundation Medicine loot booming biotech IPO market for $273M

Fierce Biotech

Wed, 09/25/13 - 09:29 am

Foundation Medicine

Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness

Fierce Biotech

Fri, 08/16/13 - 10:52 am

wet age-related macular degeneration

Regeneron drops 6% after Ophthotech reports positive data

The Fly on the Wall

Wed, 06/13/12 - 12:01 pm

Pages